Swiss Biotechs Gain Momentum with FDA Fast Track Option for Palmoplantar Pustulosis

A trio of Swiss biotechnology companies is advancing diverse therapeutic pipelines, with recent developments spanning inflammatory skin disease, immune‑mediated hair loss, and hard‑to‑treat cancers. Together, these milestones highlight how distinct…

Continue Reading Swiss Biotechs Gain Momentum with FDA Fast Track Option for Palmoplantar Pustulosis
What You Need to Know About Primary Periodic Paralysis
Source: Pixabay

What You Need to Know About Primary Periodic Paralysis

1. Rare Neuromuscular Disease Primary periodic paralysis (PPP) is group of rare neuromuscular diseases characterized by disrupted communication between nerves cells and skeletal muscles. PPP is a result of failures…

Continue Reading What You Need to Know About Primary Periodic Paralysis